Abbott Laboratories (ABT) EBIT (QoQ) (2009 - 2026)
Abbott Laboratories (ABT) EBIT (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.87% |
| Mar 31, 2026 | -40.25% |
| Dec 31, 2025 | 9.43% |
| Sep 30, 2025 | 0.24% |
| Jun 30, 2025 | 21.20% |
| Mar 31, 2025 | -11.41% |
| Dec 31, 2024 | 2.80% |
| Sep 30, 2024 | 11.38% |
| Jun 30, 2024 | 20.42% |
| Mar 31, 2024 | -22.13% |
| Dec 31, 2023 | 8.08% |
| Sep 30, 2023 | 6.81% |
| Jun 30, 2023 | 2.19% |
| Mar 31, 2023 | 15.72% |
| Dec 31, 2022 | -26.33% |
| Sep 30, 2022 | -25.51% |
| Jun 30, 2022 | -18.41% |
| Mar 31, 2022 | 22.46% |
| Dec 31, 2021 | -6.60% |
| Sep 30, 2021 | 82.90% |